These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15661021)

  • 1. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
    Lougaris V; Badolato R; Ferrari S; Plebani A
    Immunol Rev; 2005 Feb; 203():48-66. PubMed ID: 15661021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 ligand and its role in X-linked hyper-IgM syndrome.
    Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
    Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
    Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
    J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
    Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
    Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM.
    Ferrari S; Giliani S; Insalaco A; Al-Ghonaium A; Soresina AR; Loubser M; Avanzini MA; Marconi M; Badolato R; Ugazio AG; Levy Y; Catalan N; Durandy A; Tbakhi A; Notarangelo LD; Plebani A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12614-9. PubMed ID: 11675497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
    Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
    J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
    Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
    Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
    DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
    Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
    Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
    J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L.
    Bonnefoy JY; Gauchat JF; Life P; Graber P; Mazzei G; Aubry JP
    Eur Respir J Suppl; 1996 Aug; 22():63s-66s. PubMed ID: 8871046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
    Bhushan A; Covey LR
    Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
    Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
    Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.
    Bajorath J; Seyama K; Nonoyama S; Ochs HD; Aruffo A
    Protein Sci; 1996 Mar; 5(3):531-4. PubMed ID: 16509032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.
    Weller S; Faili A; Garcia C; Braun MC; Le Deist F F; de Saint Basile G G; Hermine O; Fischer A; Reynaud CA; Weill JC
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1166-70. PubMed ID: 11158612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
    Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
    J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.
    Durandy A; Revy P; Imai K; Fischer A
    Immunol Rev; 2005 Feb; 203():67-79. PubMed ID: 15661022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
    Sacco MG; Ungari M; Catò EM; Villa A; Strina D; Notarangelo LD; Jonkers J; Zecca L; Facchetti F; Vezzoni P
    Cancer Gene Ther; 2000 Oct; 7(10):1299-306. PubMed ID: 11059686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.
    Ochs HD; Hollenbaugh D; Aruffo A
    Semin Immunol; 1994 Oct; 6(5):337-41. PubMed ID: 7532462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.